Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis

In the American College of Cardiology/American Heart Association guidelines, patients are considered to have true-severe stenosis when the mean gradient (MG) is ≥40 mm Hg with an aortic valve area (AVA) ≤1 cm2 during dobutamine stress echocardiography (DSE). However, these criteria have not been pre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2018-02, Vol.71 (5), p.475-485
Hauptverfasser: Annabi, Mohamed-Salah, Touboul, Eden, Dahou, Abdellaziz, Burwash, Ian G., Bergler-Klein, Jutta, Enriquez-Sarano, Maurice, Orwat, Stefan, Baumgartner, Helmut, Mascherbauer, Julia, Mundigler, Gerald, Cavalcante, João L., Larose, Éric, Pibarot, Philippe, Clavel, Marie-Annick
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 485
container_issue 5
container_start_page 475
container_title Journal of the American College of Cardiology
container_volume 71
creator Annabi, Mohamed-Salah
Touboul, Eden
Dahou, Abdellaziz
Burwash, Ian G.
Bergler-Klein, Jutta
Enriquez-Sarano, Maurice
Orwat, Stefan
Baumgartner, Helmut
Mascherbauer, Julia
Mundigler, Gerald
Cavalcante, João L.
Larose, Éric
Pibarot, Philippe
Clavel, Marie-Annick
description In the American College of Cardiology/American Heart Association guidelines, patients are considered to have true-severe stenosis when the mean gradient (MG) is ≥40 mm Hg with an aortic valve area (AVA) ≤1 cm2 during dobutamine stress echocardiography (DSE). However, these criteria have not been previously validated. The aim of this study was to assess the value of these criteria to predict the presence of true-severe AS and the occurrence of death in patients with low-flow, low-gradient aortic stenosis (LF-LG AS). One hundred eighty-six patients with low left ventricular ejection fraction (LVEF) LF-LG AS were prospectively recruited and underwent DSE, with measurement of the MG, AVA, and the projected AVA (AVAProj), which is an estimate of the AVA at a standardized normal flow rate. Severity of AS was independently corroborated by macroscopic evaluation of the valve at the time of valve replacement in 54 patients, by measurement of the aortic valve calcium by computed tomography in 25 patients, and by both methods in 8 patients. According to these assessments, 50 of 87 (57%) patients in the study cohort had true-severe stenosis. Peak stress MG ≥40 mm Hg, peak stress AVA ≤1 cm2, and the combination of peak stress MG ≥40 mm Hg and peak stress AVA ≤1 cm2 correctly classified AS severity in 48%, 60%, and 47% of patients, respectively, whereas AVAProj ≤1 cm2 was better than all the previous markers (p < 0.007), with 70% correct classification. Among the subset of 88 patients managed conservatively (47% of the cohort), 52 died during a follow-up of 2.8 ± 2.5 years. After adjustment for age, sex, functional capacity, chronic kidney failure, and peak stress LVEF, peak stress MG and AVA were not predictors of mortality in this subset. In contrast, AVAProj ≤1 cm2 was a strong predictor of mortality under medical management (hazard ratio: 3.65; p = 0.0003). In patients with low LVEF LF-LG AS, the DSE criteria of a peak stress MG ≥40 mm Hg, or the composite of a peak stress MG ≥40 mm Hg and a peak stress AVA ≤1 cm2 proposed in the guidelines to identify true-severe AS and recommend valve replacement, have limited value to predict actual stenosis severity and outcomes. In contrast, AVAProj better distinguishes true-severe AS from pseudo-severe AS and is strongly associated with mortality in patients under conservative management. (Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis [TOPAS]; NCT01835028) [Display omitted]
doi_str_mv 10.1016/j.jacc.2017.11.052
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1999191845</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109717417785</els_id><sourcerecordid>2007528462</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-3eaf715930019f4d3308ea378280bd0cdecc57921c439e81b2c9a6dc2f95a6a03</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhi0EokvhBTigSFw4kDBjx0kscalKW5AWcSgckeW1J62jTbzYCVXfps_SJ8PLFg4cOM1I8_2_Rh9jLxEqBGzeDdVgrK04YFshViD5I7ZCKbtSSNU-ZitohSwRVHvEnqU0AEDToXrKjriq8ypxxb5_CJtlNqOfqLicI6VUnNnrYE10PlxFs7u-LfoQ7-8-m8lc0UjTXIS-WIeb8nwbbt7-3i6icX5_OQlx9vb-7nKmKSSfnrMnvdkmevEwj9m387Ovpx_L9ZeLT6cn69LWEuZSkOlblEoAoOprJwR0ZETb8Q42Dqwja2WrONpaKOpww60yjbO8V9I0BsQxe3Po3cXwY6E069EnS9utmSgsSaNSChV2tczo63_QISxxyt9pDtBK3tUNzxQ_UDaGlCL1ehf9aOKtRtB7-XrQe_l6L18j6iw_h149VC-bkdzfyB_bGXh_ACi7-Okp6mSzN0vOR7KzdsH_r_8XnbqWZA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007528462</pqid></control><display><type>article</type><title>Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis</title><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Annabi, Mohamed-Salah ; Touboul, Eden ; Dahou, Abdellaziz ; Burwash, Ian G. ; Bergler-Klein, Jutta ; Enriquez-Sarano, Maurice ; Orwat, Stefan ; Baumgartner, Helmut ; Mascherbauer, Julia ; Mundigler, Gerald ; Cavalcante, João L. ; Larose, Éric ; Pibarot, Philippe ; Clavel, Marie-Annick</creator><creatorcontrib>Annabi, Mohamed-Salah ; Touboul, Eden ; Dahou, Abdellaziz ; Burwash, Ian G. ; Bergler-Klein, Jutta ; Enriquez-Sarano, Maurice ; Orwat, Stefan ; Baumgartner, Helmut ; Mascherbauer, Julia ; Mundigler, Gerald ; Cavalcante, João L. ; Larose, Éric ; Pibarot, Philippe ; Clavel, Marie-Annick</creatorcontrib><description>In the American College of Cardiology/American Heart Association guidelines, patients are considered to have true-severe stenosis when the mean gradient (MG) is ≥40 mm Hg with an aortic valve area (AVA) ≤1 cm2 during dobutamine stress echocardiography (DSE). However, these criteria have not been previously validated. The aim of this study was to assess the value of these criteria to predict the presence of true-severe AS and the occurrence of death in patients with low-flow, low-gradient aortic stenosis (LF-LG AS). One hundred eighty-six patients with low left ventricular ejection fraction (LVEF) LF-LG AS were prospectively recruited and underwent DSE, with measurement of the MG, AVA, and the projected AVA (AVAProj), which is an estimate of the AVA at a standardized normal flow rate. Severity of AS was independently corroborated by macroscopic evaluation of the valve at the time of valve replacement in 54 patients, by measurement of the aortic valve calcium by computed tomography in 25 patients, and by both methods in 8 patients. According to these assessments, 50 of 87 (57%) patients in the study cohort had true-severe stenosis. Peak stress MG ≥40 mm Hg, peak stress AVA ≤1 cm2, and the combination of peak stress MG ≥40 mm Hg and peak stress AVA ≤1 cm2 correctly classified AS severity in 48%, 60%, and 47% of patients, respectively, whereas AVAProj ≤1 cm2 was better than all the previous markers (p &lt; 0.007), with 70% correct classification. Among the subset of 88 patients managed conservatively (47% of the cohort), 52 died during a follow-up of 2.8 ± 2.5 years. After adjustment for age, sex, functional capacity, chronic kidney failure, and peak stress LVEF, peak stress MG and AVA were not predictors of mortality in this subset. In contrast, AVAProj ≤1 cm2 was a strong predictor of mortality under medical management (hazard ratio: 3.65; p = 0.0003). In patients with low LVEF LF-LG AS, the DSE criteria of a peak stress MG ≥40 mm Hg, or the composite of a peak stress MG ≥40 mm Hg and a peak stress AVA ≤1 cm2 proposed in the guidelines to identify true-severe AS and recommend valve replacement, have limited value to predict actual stenosis severity and outcomes. In contrast, AVAProj better distinguishes true-severe AS from pseudo-severe AS and is strongly associated with mortality in patients under conservative management. (Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis [TOPAS]; NCT01835028) [Display omitted]</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2017.11.052</identifier><identifier>PMID: 29406851</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aortic stenosis ; Aortic valve ; Calcification ; Calcium ; Cardiology ; Cardiovascular disease ; Computed tomography ; Coronary vessels ; Criteria ; Echocardiography ; Electrocardiography ; Flow velocity ; Guidelines ; Heart ; Hypertension ; LV dysfunction ; Medical imaging ; Mercury ; Mortality ; Patients ; Renal failure ; Stenosis ; Stress ; stress echocardiography ; Stresses ; Stroke ; survival ; Ventricle</subject><ispartof>Journal of the American College of Cardiology, 2018-02, Vol.71 (5), p.475-485</ispartof><rights>2018 American College of Cardiology Foundation</rights><rights>Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Feb 6, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-3eaf715930019f4d3308ea378280bd0cdecc57921c439e81b2c9a6dc2f95a6a03</citedby><cites>FETCH-LOGICAL-c450t-3eaf715930019f4d3308ea378280bd0cdecc57921c439e81b2c9a6dc2f95a6a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacc.2017.11.052$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29406851$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Annabi, Mohamed-Salah</creatorcontrib><creatorcontrib>Touboul, Eden</creatorcontrib><creatorcontrib>Dahou, Abdellaziz</creatorcontrib><creatorcontrib>Burwash, Ian G.</creatorcontrib><creatorcontrib>Bergler-Klein, Jutta</creatorcontrib><creatorcontrib>Enriquez-Sarano, Maurice</creatorcontrib><creatorcontrib>Orwat, Stefan</creatorcontrib><creatorcontrib>Baumgartner, Helmut</creatorcontrib><creatorcontrib>Mascherbauer, Julia</creatorcontrib><creatorcontrib>Mundigler, Gerald</creatorcontrib><creatorcontrib>Cavalcante, João L.</creatorcontrib><creatorcontrib>Larose, Éric</creatorcontrib><creatorcontrib>Pibarot, Philippe</creatorcontrib><creatorcontrib>Clavel, Marie-Annick</creatorcontrib><title>Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>In the American College of Cardiology/American Heart Association guidelines, patients are considered to have true-severe stenosis when the mean gradient (MG) is ≥40 mm Hg with an aortic valve area (AVA) ≤1 cm2 during dobutamine stress echocardiography (DSE). However, these criteria have not been previously validated. The aim of this study was to assess the value of these criteria to predict the presence of true-severe AS and the occurrence of death in patients with low-flow, low-gradient aortic stenosis (LF-LG AS). One hundred eighty-six patients with low left ventricular ejection fraction (LVEF) LF-LG AS were prospectively recruited and underwent DSE, with measurement of the MG, AVA, and the projected AVA (AVAProj), which is an estimate of the AVA at a standardized normal flow rate. Severity of AS was independently corroborated by macroscopic evaluation of the valve at the time of valve replacement in 54 patients, by measurement of the aortic valve calcium by computed tomography in 25 patients, and by both methods in 8 patients. According to these assessments, 50 of 87 (57%) patients in the study cohort had true-severe stenosis. Peak stress MG ≥40 mm Hg, peak stress AVA ≤1 cm2, and the combination of peak stress MG ≥40 mm Hg and peak stress AVA ≤1 cm2 correctly classified AS severity in 48%, 60%, and 47% of patients, respectively, whereas AVAProj ≤1 cm2 was better than all the previous markers (p &lt; 0.007), with 70% correct classification. Among the subset of 88 patients managed conservatively (47% of the cohort), 52 died during a follow-up of 2.8 ± 2.5 years. After adjustment for age, sex, functional capacity, chronic kidney failure, and peak stress LVEF, peak stress MG and AVA were not predictors of mortality in this subset. In contrast, AVAProj ≤1 cm2 was a strong predictor of mortality under medical management (hazard ratio: 3.65; p = 0.0003). In patients with low LVEF LF-LG AS, the DSE criteria of a peak stress MG ≥40 mm Hg, or the composite of a peak stress MG ≥40 mm Hg and a peak stress AVA ≤1 cm2 proposed in the guidelines to identify true-severe AS and recommend valve replacement, have limited value to predict actual stenosis severity and outcomes. In contrast, AVAProj better distinguishes true-severe AS from pseudo-severe AS and is strongly associated with mortality in patients under conservative management. (Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis [TOPAS]; NCT01835028) [Display omitted]</description><subject>Aortic stenosis</subject><subject>Aortic valve</subject><subject>Calcification</subject><subject>Calcium</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Computed tomography</subject><subject>Coronary vessels</subject><subject>Criteria</subject><subject>Echocardiography</subject><subject>Electrocardiography</subject><subject>Flow velocity</subject><subject>Guidelines</subject><subject>Heart</subject><subject>Hypertension</subject><subject>LV dysfunction</subject><subject>Medical imaging</subject><subject>Mercury</subject><subject>Mortality</subject><subject>Patients</subject><subject>Renal failure</subject><subject>Stenosis</subject><subject>Stress</subject><subject>stress echocardiography</subject><subject>Stresses</subject><subject>Stroke</subject><subject>survival</subject><subject>Ventricle</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kMFu1DAQhi0EokvhBTigSFw4kDBjx0kscalKW5AWcSgckeW1J62jTbzYCVXfps_SJ8PLFg4cOM1I8_2_Rh9jLxEqBGzeDdVgrK04YFshViD5I7ZCKbtSSNU-ZitohSwRVHvEnqU0AEDToXrKjriq8ypxxb5_CJtlNqOfqLicI6VUnNnrYE10PlxFs7u-LfoQ7-8-m8lc0UjTXIS-WIeb8nwbbt7-3i6icX5_OQlx9vb-7nKmKSSfnrMnvdkmevEwj9m387Ovpx_L9ZeLT6cn69LWEuZSkOlblEoAoOprJwR0ZETb8Q42Dqwja2WrONpaKOpww60yjbO8V9I0BsQxe3Po3cXwY6E069EnS9utmSgsSaNSChV2tczo63_QISxxyt9pDtBK3tUNzxQ_UDaGlCL1ehf9aOKtRtB7-XrQe_l6L18j6iw_h149VC-bkdzfyB_bGXh_ACi7-Okp6mSzN0vOR7KzdsH_r_8XnbqWZA</recordid><startdate>20180206</startdate><enddate>20180206</enddate><creator>Annabi, Mohamed-Salah</creator><creator>Touboul, Eden</creator><creator>Dahou, Abdellaziz</creator><creator>Burwash, Ian G.</creator><creator>Bergler-Klein, Jutta</creator><creator>Enriquez-Sarano, Maurice</creator><creator>Orwat, Stefan</creator><creator>Baumgartner, Helmut</creator><creator>Mascherbauer, Julia</creator><creator>Mundigler, Gerald</creator><creator>Cavalcante, João L.</creator><creator>Larose, Éric</creator><creator>Pibarot, Philippe</creator><creator>Clavel, Marie-Annick</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20180206</creationdate><title>Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis</title><author>Annabi, Mohamed-Salah ; Touboul, Eden ; Dahou, Abdellaziz ; Burwash, Ian G. ; Bergler-Klein, Jutta ; Enriquez-Sarano, Maurice ; Orwat, Stefan ; Baumgartner, Helmut ; Mascherbauer, Julia ; Mundigler, Gerald ; Cavalcante, João L. ; Larose, Éric ; Pibarot, Philippe ; Clavel, Marie-Annick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-3eaf715930019f4d3308ea378280bd0cdecc57921c439e81b2c9a6dc2f95a6a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aortic stenosis</topic><topic>Aortic valve</topic><topic>Calcification</topic><topic>Calcium</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Computed tomography</topic><topic>Coronary vessels</topic><topic>Criteria</topic><topic>Echocardiography</topic><topic>Electrocardiography</topic><topic>Flow velocity</topic><topic>Guidelines</topic><topic>Heart</topic><topic>Hypertension</topic><topic>LV dysfunction</topic><topic>Medical imaging</topic><topic>Mercury</topic><topic>Mortality</topic><topic>Patients</topic><topic>Renal failure</topic><topic>Stenosis</topic><topic>Stress</topic><topic>stress echocardiography</topic><topic>Stresses</topic><topic>Stroke</topic><topic>survival</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Annabi, Mohamed-Salah</creatorcontrib><creatorcontrib>Touboul, Eden</creatorcontrib><creatorcontrib>Dahou, Abdellaziz</creatorcontrib><creatorcontrib>Burwash, Ian G.</creatorcontrib><creatorcontrib>Bergler-Klein, Jutta</creatorcontrib><creatorcontrib>Enriquez-Sarano, Maurice</creatorcontrib><creatorcontrib>Orwat, Stefan</creatorcontrib><creatorcontrib>Baumgartner, Helmut</creatorcontrib><creatorcontrib>Mascherbauer, Julia</creatorcontrib><creatorcontrib>Mundigler, Gerald</creatorcontrib><creatorcontrib>Cavalcante, João L.</creatorcontrib><creatorcontrib>Larose, Éric</creatorcontrib><creatorcontrib>Pibarot, Philippe</creatorcontrib><creatorcontrib>Clavel, Marie-Annick</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Annabi, Mohamed-Salah</au><au>Touboul, Eden</au><au>Dahou, Abdellaziz</au><au>Burwash, Ian G.</au><au>Bergler-Klein, Jutta</au><au>Enriquez-Sarano, Maurice</au><au>Orwat, Stefan</au><au>Baumgartner, Helmut</au><au>Mascherbauer, Julia</au><au>Mundigler, Gerald</au><au>Cavalcante, João L.</au><au>Larose, Éric</au><au>Pibarot, Philippe</au><au>Clavel, Marie-Annick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2018-02-06</date><risdate>2018</risdate><volume>71</volume><issue>5</issue><spage>475</spage><epage>485</epage><pages>475-485</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>In the American College of Cardiology/American Heart Association guidelines, patients are considered to have true-severe stenosis when the mean gradient (MG) is ≥40 mm Hg with an aortic valve area (AVA) ≤1 cm2 during dobutamine stress echocardiography (DSE). However, these criteria have not been previously validated. The aim of this study was to assess the value of these criteria to predict the presence of true-severe AS and the occurrence of death in patients with low-flow, low-gradient aortic stenosis (LF-LG AS). One hundred eighty-six patients with low left ventricular ejection fraction (LVEF) LF-LG AS were prospectively recruited and underwent DSE, with measurement of the MG, AVA, and the projected AVA (AVAProj), which is an estimate of the AVA at a standardized normal flow rate. Severity of AS was independently corroborated by macroscopic evaluation of the valve at the time of valve replacement in 54 patients, by measurement of the aortic valve calcium by computed tomography in 25 patients, and by both methods in 8 patients. According to these assessments, 50 of 87 (57%) patients in the study cohort had true-severe stenosis. Peak stress MG ≥40 mm Hg, peak stress AVA ≤1 cm2, and the combination of peak stress MG ≥40 mm Hg and peak stress AVA ≤1 cm2 correctly classified AS severity in 48%, 60%, and 47% of patients, respectively, whereas AVAProj ≤1 cm2 was better than all the previous markers (p &lt; 0.007), with 70% correct classification. Among the subset of 88 patients managed conservatively (47% of the cohort), 52 died during a follow-up of 2.8 ± 2.5 years. After adjustment for age, sex, functional capacity, chronic kidney failure, and peak stress LVEF, peak stress MG and AVA were not predictors of mortality in this subset. In contrast, AVAProj ≤1 cm2 was a strong predictor of mortality under medical management (hazard ratio: 3.65; p = 0.0003). In patients with low LVEF LF-LG AS, the DSE criteria of a peak stress MG ≥40 mm Hg, or the composite of a peak stress MG ≥40 mm Hg and a peak stress AVA ≤1 cm2 proposed in the guidelines to identify true-severe AS and recommend valve replacement, have limited value to predict actual stenosis severity and outcomes. In contrast, AVAProj better distinguishes true-severe AS from pseudo-severe AS and is strongly associated with mortality in patients under conservative management. (Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis [TOPAS]; NCT01835028) [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29406851</pmid><doi>10.1016/j.jacc.2017.11.052</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2018-02, Vol.71 (5), p.475-485
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_miscellaneous_1999191845
source ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Aortic stenosis
Aortic valve
Calcification
Calcium
Cardiology
Cardiovascular disease
Computed tomography
Coronary vessels
Criteria
Echocardiography
Electrocardiography
Flow velocity
Guidelines
Heart
Hypertension
LV dysfunction
Medical imaging
Mercury
Mortality
Patients
Renal failure
Stenosis
Stress
stress echocardiography
Stresses
Stroke
survival
Ventricle
title Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A35%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dobutamine%20Stress%20Echocardiography%20for%C2%A0Management%20of%20Low-Flow,%20Low-Gradient%20Aortic%C2%A0Stenosis&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Annabi,%20Mohamed-Salah&rft.date=2018-02-06&rft.volume=71&rft.issue=5&rft.spage=475&rft.epage=485&rft.pages=475-485&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2017.11.052&rft_dat=%3Cproquest_cross%3E2007528462%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2007528462&rft_id=info:pmid/29406851&rft_els_id=S0735109717417785&rfr_iscdi=true